ACM
SCPH

AIGH Capital Management’s scPharmaceuticals SCPH Stock Holding History

AIGH Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,867,523
Closed -$14.7M – 51
2025
Q2 		$14.7M Sell
3,867,523
-228,844
-6% -$710K 6.63% 3
2025
Q1 		$10.8M Sell
4,096,367
-78,000
-2% -$254K 4.46% 6
2024
Q4 		$14.8M Buy
4,174,367
+50,000
+1% +$192K 4.62% 8
2024
Q3 		$18.8M Buy
4,124,367
+620,002
+18% +$3M 5.3% 4
2024
Q2 		$15.2M Buy
3,504,365
+115,206
+3% +$506K 4.75% 6
2024
Q1 		$17M Buy
3,389,159
+282,364
+9% +$1.58M 5.11% 3
2023
Q4 		$19.5M Buy
3,106,795
+899,786
+41% +$5.15M 7.71% 2
2023
Q3 		$15.7M Buy
2,207,009
+155,204
+8% +$1.22M 7.44% 2
2023
Q2 		$20.9M Sell
2,051,805
-23,992
-1% -$250K 8.53% 2
2023
Q1 		$18.8M Sell
2,075,797
-474,437
-19% -$3.48M 6.94% 2
2022
Q4 		$18.3M Buy
2,550,234
+1,793,171
+237% +$11M 6.02% 5
2022
Q3 		$4.94M Sell
757,063
-589,661
-44% -$3.15M 1.53% 18
2022
Q2 		$6.49M Sell
1,346,724
-50,000
-4% -$247K 1.71% 16
2022
Q1 		$7.93M Buy
1,396,724
+23,600
+2% +$116K 1.95% 16
2021
Q4 		$6.89M Buy
1,373,124
+139,003
+11% +$765K 2.1% 14
2021
Q3 		$8.21M Buy
1,234,121
+591,967
+92% +$3.54M 1.73% 17
2021
Q2 		$3.92M Sell
642,154
-212,988
-25% -$1.28M 0.71% 29
2021
Q1 		$5.69M Buy
855,142
+217,820
+34% +$1.49M 1.2% 24
2020
Q4 		$3.37M Buy
+637,322
New +$4.99M 1.37% 22

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

AIGH Capital Management's SCPH Position: Q3 2025 in Review

AIGH Capital Management sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 3,867,523 shares — an estimated $14.7M sold.

AIGH Capital Management first reported a position in SCPH in Q4 2020 and held it in 19 quarters. The position peaked at $20.9M in Q2 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

  • AIGH Capital Management reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • AIGH Capital Management sold 3,867,523 scPharmaceuticals shares in Q3 2025, an estimated $14.7M.
  • AIGH Capital Management first reported a position in scPharmaceuticals in Q4 2020 and held it in 19 quarters.
  • AIGH Capital Management's scPharmaceuticals position peaked at $20.9M in Q2 2023.
  • 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on AIGH Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.